Side-by-side comparison of AI visibility scores, market position, and capabilities
London ADHD management app with CBT and coaching for adults managing ADHD without relying solely on medication; $16.7M Octopus Ventures Series A with 100K+ downloads competing with Done and Cerebral.
Inflow is a London-based digital health company providing a science-based self-management app for adults with ADHD — backed with $16.7 million raised including an $11 million Series A led by Octopus Ventures in 2023 — delivering cognitive behavioral therapy (CBT), psychoeducation, ADHD coaching, and evidence-based habit management tools through a mobile app that helps adults understand and manage their ADHD without relying exclusively on medication. Founded in 2020, Inflow acquired Lina Health in 2022 to expand telehealth capabilities and has achieved 100,000+ downloads, serving adults who are newly diagnosed, managing ADHD alongside medication, or seeking non-pharmacological coping strategies.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.